Assessing Blood Clotting and Coagulation Factors in Mice.

Area of Science:

• Biochemistry
• Physiology
• Genetics

Background:

• The mammalian blood coagulation system balances hemostasis and blood fluidity.
• Genetic variations significantly impact coagulation across mouse strains, with many factors yet undiscovered.
• Genetically modified mouse models offer new avenues for studying coagulation regulation.

Purpose of the Study:

• To provide standardized protocols for assessing in vivo and in vitro blood coagulation.
• To facilitate the identification of novel genetic variants affecting hemostasis.
• To enable the characterization of specific coagulation factors.

Main Methods:

• Tail bleeding time assay for in vivo coagulation assessment.
• In vitro assays including prothrombin time, activated partial thromboplastin time, and thrombin generation.
• Protocols for evaluating specific known coagulation factor activities.

Main Results:

• Established comprehensive protocols for evaluating blood coagulation parameters.
• Demonstrated the utility of mouse models in hemostasis research.
• Provided a framework for discovering unknown coagulation-related molecules.

Conclusions:

• The presented protocols are essential for dissecting the genetic basis of blood coagulation.
• These methods support the ongoing discovery of novel hemostatic regulators.
• This work advances the understanding of mammalian hemostasis and thrombosis research.